Giuseppe Lepore

Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study

Sebastiano Bruno Solerte, Francesca D’Addio, Roberto Trevisan et al. · Diabetes Care · 2020 · 242 citations · Full text

Real-World Performance of the MiniMed™ 780G System: First Report of Outcomes from 4120 Users

Julien Da Silva, Giuseppe Lepore, Tadej Battelino et al. · Diabetes Technology & Therapeutics · 2021 · 207 citations · Full text

Effect of sodium intake on blood pressure and albuminuria in Type 2 diabetic patients: the role of insulin resistance

Monica Vedovato, Giuseppe Lepore, Anna Coracina et al. · Diabetologia · 2003 · 143 citations · Full text

Insulin Resistance, Metabolic Syndrome, Hypertension +10

Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial

Emanuele Bosi, Pratik Choudhary, Harold W. de Valk et al. · The Lancet Diabetes & Endocrinology · 2019 · 121 citations

Type 1, Hypoglycaemia-prone Adults, Diabetes Management +7

Switching to the Minimed™ 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control

Giuseppe Lepore, Alessandro Rossini, Rosalia Bellante et al. · Acta Diabetologica · 2022 · 37 citations

Metabolic Syndrome, Type 1, Diabetes Management +6